Vivos Therapeutics VVOS Stock
Vivos Therapeutics Price Chart
Vivos Therapeutics VVOS Financial and Trading Overview
| Vivos Therapeutics stock price | 0.3 USD |
| Previous Close | 0.28 USD |
| Open | 0.29 USD |
| Bid | 0.21 USD x 200 |
| Ask | 0.36 USD x 200 |
| Day's Range | 0.28 - 0.3 USD |
| 52 Week Range | 0.26 - 5.12 USD |
| Volume | 110.04K USD |
| Avg. Volume | 2.54M USD |
| Market Cap | 5.98M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.88 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.12 USD |
VVOS Valuation Measures
| Enterprise Value | 17.64M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.3607302 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.28586036 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.844 |
| Enterprise Value/EBITDA | -0.85 |
Trading Information
Vivos Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -93.57% |
| S&P500 52-Week Change | 18.67% |
| 52 Week High | 5.12 USD |
| 52 Week Low | 0.26 USD |
| 50-Day Moving Average | 0.42 USD |
| 200-Day Moving Average | 1.24 USD |
VVOS Share Statistics
| Avg. Volume (3 month) | 2.54M USD |
| Avg. Daily Volume (10-Days) | 1.21M USD |
| Shares Outstanding | 20.12M |
| Float | 14.94M |
| Short Ratio | 1.61 |
| % Held by Insiders | 27.20% |
| % Held by Institutions | 6.51% |
| Shares Short | 1.2M |
| Short % of Float | 10.81% |
| Short % of Shares Outstanding | 8.64% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -121.78% |
| Operating Margin (ttm) | -93.63% |
| Gross Margin | 61.89% |
| EBITDA Margin | -99.33% |
Management Effectiveness
| Return on Assets (ttm) | -56.18% |
| Return on Equity (ttm) | -8585.26% |
Income Statement
| Revenue (ttm) | 20.9M USD |
| Revenue Per Share (ttm) | 1.5 USD |
| Quarterly Revenue Growth (yoy) | 34.89% |
| Gross Profit (ttm) | 12.94M USD |
| EBITDA | -20763000 USD |
| Net Income Avi to Common (ttm) | -25456000 USD |
| Diluted EPS (ttm) | -1.97 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.77M USD |
| Total Cash Per Share (mrq) | 0.09 USD |
| Total Debt (mrq) | 12.51M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.207 |
| Book Value Per Share (mrq) | -0.084 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17131000 USD |
| Levered Free Cash Flow (ttm) | -7387250 USD |
Profile of Vivos Therapeutics
| Country | United States |
| State | CO |
| City | Littleton |
| Address | 7921 Southpark Plaza |
| ZIP | 80120 |
| Phone | 866 908 4867 |
| Website | https://www.vivos.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 268 |
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
Q&A For Vivos Therapeutics Stock
What is a current VVOS stock price?
Vivos Therapeutics VVOS stock price today per share is 0.3 USD.
How to purchase Vivos Therapeutics stock?
You can buy VVOS shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vivos Therapeutics?
The stock symbol or ticker of Vivos Therapeutics is VVOS.
Which industry does the Vivos Therapeutics company belong to?
The Vivos Therapeutics industry is Medical Devices.
How many shares does Vivos Therapeutics have in circulation?
The max supply of Vivos Therapeutics shares is 20.12M.
What is Vivos Therapeutics Price to Earnings Ratio (PE Ratio)?
Vivos Therapeutics PE Ratio is now.
What was Vivos Therapeutics earnings per share over the trailing 12 months (TTM)?
Vivos Therapeutics EPS is -1.88 USD over the trailing 12 months.
Which sector does the Vivos Therapeutics company belong to?
The Vivos Therapeutics sector is Healthcare.
Vivos Therapeutics VVOS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26180.46 USD — |
+0.43
|
6.32B USD — | 26049.3 USD — | 26269.85 USD — | — - | 6.32B USD — |
|
US Tech Health Care
IXHC
US
|
1367.82 USD — |
+1.36
|
— — | 1351.7 USD — | 1374.29 USD — | — - | — — |
- {{ link.label }} {{link}}
